Hansen Medical (NSDQ:HNSN) said its Magellan surgical robotics system was used in the 1st robotic fibroid embolization performed in the U.S.
Ablative Solutions tests infusion ablation catheter as hypertension treatment
Diabetes: Medtronic initiates IDE trial for new insulin management system
ZipLine Medical adds $5.7m to Series C round
ZipLine Medical said it added a $5.7 million extension to its $4.3 million Series C round, with new investor China Materialia promising to help the company expand sales in the People’s Republic.
FDA clears AnthroTronix mobile app for PTSD, brain trauma assessment
Breast implant maker Sientra sets IPO range
Breast implant maker Sientra set a price range for its planned initial public offering and raised the upper limit to $92 million, after filing in mid-September for an $86 million IPO.
FDA approves TriVascular’s CustomSeal for aortic aneurysms
Sinopsys Surgical sniffs up $8.3m for sinusitis device
Stealth-mode startup Sinopsys Surgical said it raised $8.3 million in an equity funding round for the technique it’s developing to repurpose the tear duct to drain into the sinuses as a way to relieve chronic sinusitis.
CEO Dr. Harry Ross was a partner with Aweida Venture Partners of Superior, Colo., near to Sinopsys Surgical’s Boulder headquarters.